Report: Sanofi will invest in Japanese firm to enter generics market

05/26/2010 | Reuters

Sanofi-Aventis will buy a stake of almost 5% in Japan's Nichi-Iko Pharmaceutical for about $55 million in a bid to enter the country's generic-drug market, according to a newspaper report. The companies also plan to create a joint venture and team up in developing bioengineered drugs, the report states.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD